Ñî¹óåú´«Ã½Ò•îl

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • Ñî¹óåú´«Ã½Ò•îl Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 10 2026 UPDATED 10:06 AM

Full Issue

Medical Journal Retracts Liver Transplant Studies Over Concern Organs Were 'Procured Unethically'

The two Chinese studies were published more than a decade ago in the Journal of Hepatology, MedPage Today reports. Other research news is on diabetes drugs and autoimmunity risk; long covid and heart-related fitness; and more.

Two Chinese studies related to liver transplantation published more than a decade ago in the Journal of Hepatology were retracted by the journal's editors. The editors said concerns were raised that the transplants described in both studies may have involved organs "procured unethically." (Bassett, 7/9)

Analysis of hundreds of thousands of patient records showed differing risks for autoimmune disorders for new users of the more recent types of antidiabetic medications. (Gever, 7/9)

Treatment with setmelanotide (Imcivree), a melanocortin-4 receptor (MC4R) agonist, led to significant reductions in body mass index (BMI) and hunger in individuals with acquired hypothalamic obesity, the phase III TRANSCEND trial showed. (Monaco, 7/9)

People with long COVID often report fatigue and other symptoms that make it challenging for them to enjoy life like they once did. A study published recently in JACC: Advances found that people with more long-COVID symptoms are less active and have poorer cardiovascular health measures. But more investigation is needed to understand the relationship between activity levels and cardiovascular disease (CVD) for those with long COVID. (Holohan, 7/9)

Long-lasting vision problems following mild cases of COVID-19 may stem from persistent inflammation and nerve damage, even as the results of standard eye examinations appear normal, according to a study today in Nature Communications. Although less well-known than other long-COVID symptoms, ocular symptoms like pain, light sensitivity, blurred vision, and difficulty reading affect up to 31% to 35% of people with the condition, the study authors note. But this abnormal eye behavior can’t be detected by standard methods, making it difficult for patients to get a diagnosis or treatment. (Bergeson, 7/9)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 10
  • Thursday, July 9
  • Wednesday, July 8
  • Tuesday, July 7
  • Monday, July 6
  • Thursday, July 2
More Morning Briefings
RSS Feeds
  • Ñî¹óåú´«Ã½Ò•îl
  • Special Reports
  • Morning Briefing
  • About Us
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF